Home/Filings/4/0000899243-22-011659
4//SEC Filing

Erickson Bruce Kipp 4

Accession 0000899243-22-011659

CIK 0001833214other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 9:15 PM ET

Size

5.6 KB

Accession

0000899243-22-011659

Insider Transaction Report

Form 4
Period: 2022-03-16
Erickson Bruce Kipp
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-03-16+18,19618,196 total
    Exercise: $1.78Exp: 2032-03-16Common Stock (18,196 underlying)
Footnotes (2)
  • [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
  • [F2]The shares underlying the option will vest in full on the one-year anniversary of March 16, 2022, the date the award was approved by the Company's board of directors.

Issuer

SAB Biotherapeutics, Inc.

CIK 0001833214

Entity typeother

Related Parties

1
  • filerCIK 0001889685

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:15 PM ET
Size
5.6 KB